SEP 27, 2019 08:37 AM PDT

AI Exponentially Accelerates Drug Development

WRITTEN BY: Annie Lennon

Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial intelligence technology however, this process is both becoming more cost-efficient and shorter, something that is expected to exponentially accelerate the development of new drugs. 

According to Brendan Frey, founder and CEO of AI-based drug discovery company, Deep Genomics, developing drugs has traditionally been like gambling, “It’s like the Big Pharma companies come into a casino, put a million-dollar coin into a slot machine and with some probability like 10% or something, they get a win (Robertson: 2019).”

This is where AI comes in. Until now, Deep Genomics has developed over 20 machine learning systems trained from both public and proprietary data to screen for disease-causing mutations while looking for drug targets. In just two hours, their technology can screen over 200,000 pathogenic mutations and automatically suggest potential drug targets.

Frey said, “I am certain that we are witnessing a new era of drug discovery… Our AI systems can figure out how diseases are caused and how to fix those diseases much more rapidly than humans ever could and also with a greater success rate (ibid.).”

In particular, Frey and his team have used their machine learning systems to find potential drugs for Wilson's disease, a rare genetic disorder that leads to excessive build-up of copper in various body tissues. If left untreated, it can cause liver disease and central nervous system dysfunction, ultimately leading to death (Rare Disease Database: 2019). Although current drugs m to reduce copper levels in the body by stopping their absorption from food, no treatments have yet been made to restore the body’s natural ability to remove the metal. 

Using Deep Genomics AI however, Frey and his team were both able to understand how a mutation changes an amino acid in a copper-binding protein, an identify 24 potential new drug candidates. After testing these further, they were then able to announce a candidate for further development as an investigational new drug (Philippidis: 2019). 

With such a process usually taking around 17 years now possible in just 18 months, Frederick Askari, the Director of the Wilson Disease Program at the University of Michigan said: ”The clarity that this artificial intelligence platform has brought to the scientific community is astounding and the potential of a therapy that could operate at the genomic level to correct the disease process is exciting.”


 

Sources

 

Roberston, Sally: News Medical 

Rare Disease Database: National Organization for Rare Disorders 

Philippidis, Alex: Genetic Engineering and Biotechnology News

About the Author
  • Writer with a keen interest in genetics, psychology, health and everything in between. Currently focused on the interplay of genetics and society to understand how to create meaningful interactions and environments.
You May Also Like
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Unprecedented Therapeutic Found Effective for Blood Cancer
According to the findings of a clinical trial, scientists at Mt. Sinai have found a new therapeutic effective for patients with a particular type of b...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
How does a drug for colorectal cancer work?
Colorectal cancer is a fatal and common disease, and treatment decisions are often based on what genes have been mutated in the development of the cancer. ...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Compound in Daffodils Can Help Fight Cancer
Preventing the growth of tumors presents a challenge for scientists in finding a cure to cancer. Now however, researchers from the University Libre de Brux...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Nanomesh Development Advances Drug Delivery's Fight Against Antibiotic-Resistance
As concern over medication-resistant bacteria grows, researchers at Flinders University have now fabricated nanomeshes as an effective drug delivery method...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Common Therapeutic Can Treat Bleeding Associated with Traumatic Brain Injury
An inexpensive and accessible drug was found to reduce rates of mortality associated with traumatic brain injury (TBI) patients by 20%. TBI is a major caus...
NOV 18, 2019
Health & Medicine
NOV 18, 2019
FDA Cautions Against Cannabis Use During Pregnancy
A recent article published by NPR addresses the rapidly growing number of females using cannabis during pregnancy. Those with tough pregnancy side effects ...
Loading Comments...